Challenge
This top 20 pharma Global Medical Affairs group needed to optimise IEGP and Medical planning for a priority asset across pre/peri/post-launch with an Alliance partner. Fragmented processes required an indication-tailored approach and stronger global–local and Brand alignment.
Solution
- Applied a best-practice, indication-specific framework; engaged the right functions/markets at the right time.
- Ran cross-functional workshops to set evidence drivers, medical objectives, and “bread &butter”/ “big idea” tactics.
- Delivered integrated IEGPs and Medical Plans with clear interdependencies and pull-through with Brand planning.
Outcome
- Aligned IEGPs, Medical and Brand Plans by indication, maximizing asset potential
- Reduced stakeholder burden by streamlining templates and collaborative plans
- Global–local collaboration and cross-indication tactics supporting brand goals.